We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel Breast Imaging System Proves As Effective As Mammography

By MedImaging International staff writers
Posted on 22 Apr 2024
Print article
Image: The trial found QTI’s breast acoustic CT scans to be as effective as digital breast tomosynthesis (Photo courtesy of QTI)
Image: The trial found QTI’s breast acoustic CT scans to be as effective as digital breast tomosynthesis (Photo courtesy of QTI)

Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50 today will be diagnosed before the age of 60. Various screening and diagnostic technologies are employed to detect cancers early and enhance treatment outcomes. Mammography is currently the predominant imaging method, yet it has its limitations, especially in detecting cancers in dense breast tissue where 10-15% of cases yield inconclusive results and raise safety concerns. Now, a new clinical trial has found a highly accurate, 100% safe, and painless breast imaging technology to be as effective as digital breast tomosynthesis (DBT), also known as 3D mammography.

The Breast Acoustic CT system from QT Imaging Holdings (QTI, Novato, CA, USA) represents a breakthrough in non-invasive breast imaging. This FDA-cleared system utilizes both transmission and reflection ultrasound to provide detailed and complementary information about breast tissue, enabling a more effective assessment of breast health. This cutting-edge technology produces volumetric 3D images accurately and precisely, without the need for contrast agents or exposure to radiation. The company has now announced positive results from its second blinded multi-reader multi-case study, evaluating the diagnostic efficacy of the Breast Acoustic CT Scans for mass detection.

The comparative study involved 24 breast radiologists who reviewed 177 selected cases, including 66 with cancer, atypia, or a solid mass, and 111 normal or with non-solid benign abnormalities. The results demonstrated that QTI’s Breast Acoustic CT matches the effectiveness of DBT, with the area under the receiver operating characteristic curve (AUC) showing statistical non-inferiority to DBT, within a -0.05 AUC difference margin. This confirms that QTI’s technology is comparably effective in detecting breast lesions, with high specificity in identifying benign cysts, thus potentially reducing benign recall rates. Notably, breast cancer in women under 40, while less common, tends to be more aggressive and linked to poorer survival rates. Standard screening mammograms are generally not recommended for this age group due to the balance of risks and benefits. However, the findings from this study suggest that QTI’s technology could provide a much-needed potential alternative for younger women for whom traditional mammography is not advised.

“We are encouraged by the consistent high performance of QTI’s technology, especially in women with dense breasts,” said Dr. Bilal Malik, Chief Science Officer. “Along with the previously published results and from comparison of QTI’s scans with mammography, these trial results will be valuable for our planned FDA submission for a screening indication in younger women identified with above-average risk for developing breast cancer and who have not yet reached the age for conventional mammography-based screening.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
FMT Radiographic Suite
AdvantagePlus ML1
New
Ultrasound Color LCD
U156W
New
Ultrasound System
P20 Elite

Print article

Channels

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.